Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable. The collaboration allows vital sign data from the W1 watch to be sent ...

Philips aims to broaden the reach of its digital patient monitoring platforms, from inside the hospital out to the home, through a $2.8 billion acquisition deal for BioTelemetry and its wearable heart ...

Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first ...

More than a year after doling out an emergency use authorization for a handful of Philips’ IntelliVue patient monitoring devices, the FDA is doubling down on the regulatory nod. Two of the patient ...

A year after they were given an emergency nod to be used during the pandemic, two of Royal Philips’ newest patient monitors now are cleared by the Food and Drug Administration. The agency recently ...